logo
Joint Meeting of The 3rd International Consultation on Interstitial Cystitis Japan (ICICJ) and The ESSIC Annual Meeting 2013
The 3rd International Consultation on Interstitial Cystitis, Japan 2013
International Journal of Urology Supplement 3rd International Consultation Interstitial Cystitis Japan (ICICJ) and International Society for the Study of Bladder Pain Syndrome (ESSIC) Joint Meeting 21–23 March 2013 Kyoto, Japan
Interstitial cystitis and the painful bladder: A brief history of nomenclature, definitions and criteria
Urethral sensation: Basic mechanisms and clinical expressions
Editorial Comment to Urethral sensation: Basic mechanisms and clinical expressions
Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis
Mechanisms of pain from urinary tract infection
Editorial Comment to Mechanism of pain from urinary tract infection
Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis
Editorial Comment from Dr Hanno to Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis
Editorial Comment from Dr Yoshimura to Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis
Hypersensitive bladder: A solution to confused terminology and ignorance concerning interstitial cystitis
Editorial Comment from Dr Hanno to Hypersensitive bladder: A solution to confused terminology and ignorance concerning interstitial cystitis
Editorial Comment from Dr Nordling to Hypersensitive bladder: A solution to confused terminology and ignorance concerning interstitial cystitis
Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis
Editorial Comment from Dr Yoshimura to Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis
Editorial Comment from Professor Dinis to Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis
Therapeutic efficacy of narrow band imaging-assisted transurethral electrocoagulation for ulcer-type interstitial cystitis/painful bladder syndrome
Editorial Comment to Therapeutic efficacy of narrow band imaging-assisted transurethral electrocoagulation for ulcer-type painful bladder syndrome/interstitial cystitis
Development and evaluation of an E-health system to care for patients with bladder pain syndrome/interstitial cystitis
Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner's lesion
Editorial Comment to Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner's lesion
Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis
Editorial Comment to Inflammation characteristics in bladder pain syndrome European Society for the Study of Interstitial Cystitis type 3C/classic interstitial cystitis
Interstitial cystitis is bladder pain syndrome with Hunner's lesion
Editorial Comment from Dr Hanno to Interstitial cystitis is bladder pain syndrome with Hunner's lesion
Editorial Comment from Dr Yoshimura to Interstitial cystitis is bladder pain syndrome with Hunner's lesion
Editorial Comment from Dr Ueda to Assessments of bladder pain syndrome/interstitial cystitis treatment in future trials
Gynecological disorders in bladder pain syndrome/interstitial cystitis patients
Bladder Pain Syndrome/ Interstitial CystitisUpdate in the USA
Bladder Pain Syndrome/ Interstitial CystitisUpdate in Europe
Bladder Pain Syndrome/ Interstitial Cystitis Update of IC from East Asia
Immunological diagnosis of bladder pain syndrome/interstitial cystitis
OAB- Neurologic bladder- BPS/IC
Infection/Inflammation
Definition and Terminology
Hunner lesion – Diagnostic methods
New Cystoscopic Diagnosis
Treatment of Hunner Lesion
Urothelium and Cell-Cell Interactions
Bladder Afferents
Bacterial Determinants of Pelvic Pain
Potential urine and serum biomarkers for patients with bladder pain syndrome / interstitial cystitis
Overview – pharmacology
Oral treatment
Intravesical treatment of Bladder Pain Syndrome
“Hypersensitive bladder “state of the art
IC/BPS: Future directions
Future Direction for IC/BPS Research – Asian View
Patient communication, including the sexual implications of BPS/IC
Patient communication including the sexual implications of Interstitial Cystitis (IC)
Lessons learnt from 20 years of IC /PBS
A study of interstitial cystitis/painful bladder syndrome by analyzing its clinical course
Comparison of pain between bladder pain syndrome and fibromyalgia by the device for quantitative analysis of perception and pain sensation
Therapeutic efficacy of narrow band imaging-assisted transurethral electrocoagulation for ulcer-type interstitial cystitis/painful bladder syndrome
Development and Evaluation of an E-health System for Caring Patients with Interstitial Cystitis/ Painful Bladder Syndrome
The Correlation of Urinary Bladder Weight and Female. Interstitial Cystitis/ Painful Bladder Syndrome (IC/PBS)
Development of Bladder Glomerulations after Hydrodistension in Patients with Upper Urinary Tract Urolithiasis Suggesting Cross Talk and Bladder Inflammation Occur between Upper and Lower Urinary Tract
Revisit Potassium Sensitivity Test – A Systematic Study of Its Role on Lower Urinary Tract Symptoms
Are Glomerulations after Cystoscopic Hydrodistention a Pathognomonic Sign for Interstitial Cystitis?
The Effects of Non-Bladder Comorbid Conditions on Urodynamic Characteristics of the Interstitial Cystitis/Bladder Pain Syndrome
Intravesical OnabotulinumtoxinA Injections Do Not Benefit Patients with Ulcer Type interstitial Cystitis
Repeat OnabotulinumtoxinA Injections Provide Better Therapeutic Results than Single Injection in Treatment of Painful Bladder Syndrome
Effects of additional Urapidil dosing to interstitial cystitis (IC) patients.
The use of Mirabegron for urinary urgency and frequency associated with interstitial cystitis: Early experience of five cases
Effects of Combination Treatment of Intravesical Resiniferatoxin Instillation and Hydrodistention in Patients with Refractory Painful Bladder Syndrome/Interstitial Cystitis: A Pilot Study
How to improve efficacy of intravesical instillation therapy? Advanteges of the novel method of high pressure intravesical drug delivery
The Use of Tramadol for Refractory Interstitial Cystitis: Retrospective Analysis of Fifteen Cases
The need of holistic care in women with Interstitial Cystitis / Painful Bladder Syndrome (IC/PBS) who have child abuse experience and psychiatric troubles
Efficacy and safety of augmentation ileocystoplasty with supratrigonal cystectomy for the treatment of refractory interstitial cystitis
Relaxing Cystoplasty a new approach in refractory Interstitial Cystitis: CASE REPORT
Balloon distension of the bladder instead of hydrodilation; what advantages are to be expected?
Automatic evaluation of pressure-volume relation measured during balloon- and hydrodilation of the bladder in BPS/IC patients
Chemodenervation of Hunner Lesions as a Treatment for Interstitial Cystitis / Bladder Pain Syndrome
Decreased expression of stem cell marker CD44v9 in the basal cells of bladder epithelium in patients with interstitial cystitis/bladder pain syndrome
Down Regulation of Apoptotic and Inflammatory Proteins are Associated with Improved Clinical Characteristics of Patients with Interstitial Cystitis after Repeated Intravesical Botulinum Toxin A Injections
Different Expressions of the Bladder Inflammation, Apoptosis and Barrier Proteins in Patients with Bladder Outlet Obstruction, Interstitial Cystitis, Spinal Cord Injury, Recurrent Urinary Tract Infection and Ketamine Cystitis Suggest a Similar Pathophysiology is Involved in Different Bladder Conditions
Pathological Mechanism of Therapeutic Effect of Botulinum Toxin A on Interstitial Cystitis/ Bladder Pain Syndrome
Increased Serum Cytokines and Chemokines Levels in Patients with Interstitial Cystitis / Bladder Pain Syndrome Suggest Systemic Chronic Inflammation is Involved in Pathogenesis
Decrease of Urinary Nerve Growth Factor but Not Brain-Derived Neurotrpophic Factor in Patients with Interstitial Cystitis/Bladder Pain Syndrome Successfully Treated with Hyaluronic Acid
Increased Urothelial Cell Apoptosis and Chronic Inflammation Might be the Causes of Recurrent Urinary Tract Infection in Women
Cytokine responses in BPS/IC Type 3C
Expression and function of P2X3 and NK1 receptors in rat urinary bladder with cyclophosphamide-induced cystitis
DNA microarray analysis of genes differentially expressed in the mouse bladder treated with cyclophosphamide.
The 3rd International Consultation on Interstitial Cystitis, Japan 2013